Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine, Nature Biotechnology and Nature Reviews Drug Discovery.
November 2009
2009:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010
News | News Features
News
Flu-virus prevalence comes under scrutiny
Projects to monitor the prevalence of H1N1-specific antibodies will help epidemiologists understand how many people have become infected and improve estimates of pandemic spread, severity and mortality.
Nature News (24 November 2009)
| Full Text |
Icelandic genomics firm goes bankrupt
After struggling financially for years, the genomics company deCODE, based in Reykjavik, Iceland, has filed for bankruptcy.
Nature News (23 November 2009)
| Full Text |
Diagnosing the future of genomics
Eric Green, the head of the US National Human Genome Research Institute, talks to Nature about his plans for the institute.
Nature News (23 November 2009)
| Full Text |
Japanese science faces deep cuts
Japanese researchers are in uproar about the drastic budget cuts being recommended for science projects by a new cabinet-level government advisory unit.
Nature News (19 November 2009)
| Full Text |
Plant genetics database at risk as funds run dry
The Arabidopsis Information Resource (TAIR), which maintains a free database of genetic and molecular-biology data for Arabidopsis thaliana, faces extinction as funding is phased out by the US National Science Foundation (NSF).
Nature News (19 November 2009)
| Full Text |
Growth in R&D investment holding up
Global corporate investment in research and development grew more slowly in 2008 than in 2007, but remained relatively robust despite the economic crisis.
Nature News (19 November 2009)
| Full Text |
Fresh hope for German stem-cell patent case
The German federal supreme court has referred a controversial patent dispute about human embryonic stem cells to the European Court of Justice, raising hopes that a ruling will finally settle some of the uncertainties that hamper stem-cell research in Germany.
Nature News (19 November 2009)
| Full Text |
Biologists rally to sequence 'neglected' microbes
The GenBank sequence database recently counted its thousandth complete microbial genome — but researchers are now eager to sequence the genomes of 'neglected' microbial species that lacked close relatives in GenBank.
Nature News (17 November 2009)
| Full Text |
Wellcome Trust makes it personal in funding revamp
The Wellcome Trust is giving its grant scheme a major overhaul by awarding longer-term funding focused on individual researchers, rather than on specific research projects.
Nature News (12 November 2009)
| Full Text |
European biosafety labs set to grow
A rash of new maximum-security biosafety-level-4 (BSL-4) labs are being built in the European Union, and even more are planned, but some scientists are arguing that the bloc already has more facilities than it needs.
Nature News (12 November 2009)
| Full Text |
Report row ousts top Indian scientist
The Indian Council of Scientific and Industrial Research has dismissed the first scientist that was appointed under its scheme to recruit scientists and technologists of Indian origin into researcher leadership roles.
Nature News (12 November 2009)
| Full Text |
Evolution of single gene linked to language
The human FOXP2 gene differs from that of chimps in just two places, but the functional effects of those nonconserved residues could help explain the differences between chimp and human brain development, and why only humans are capable of language.
Nature News (11 November 2009)
| Full Text |
Genentech obtains proof of concept for hedgehog inhibition
Results from a phase 1 clinical trial suggest that Genentech's small-molecule hedgehog pathway inhibitor has potent antitumor activity in basal cell carcinoma.
Nature Biotechnology News (November 2009)
| Full Text |
Australian committees set to advise on translational medicine
Australia's National Health and Medical Research Council (NHMRC) has approved two new principal committees that will provide advice on translational medicine and public health.
Nature Medicine News (November 2009)
| Full Text |
10,000 genomes to come
As results begin to arrive from the 1000 Genomes Project, an international group is planning a new initiative — Genome 10K — that aims to sequence the genomes of thousands of vertebrate species.
Nature News (5 November 2009)
| Full Text |
California stem-cell grants awarded
The California Institute for Regenerative Medicine (CIRM) has awarded US$230 million in grants to support research on experimental stem-cell treatments.
Nature News (5 November 2009)
| Full Text |
Science favoured by German coalition
The budgets for education and research in Germany are set to almost double over the next four-year legislative period.
Nature News (5 November 2009)
| Full Text |
Science at the Smithsonian
Nature talks to plant biologist Eva Pell, who will become the undersecretary for science at the Smithsonian Institution in January 2010.
Nature News (4 November 2009)
| Full Text |
Sacked science adviser speaks out
Psychopharmacologist David Nutt speaks out about his forced resignation from the UK Advisory Council on the Misuse of Drugs (ACMD).
Nature News (2 November 2009)
| Full Text |
New targets for old drugs
A computer program that compares the chemical similarities between drug compounds and other molecules already known to bind to each drug target has revealed thousands of new targets for existing drugs.
Nature News (1 November 2009)
| Full Text |
First oral therapies for multiple sclerosis anticipated
With five novel oral therapies in late-stage development, a wide range of treatment options for relapsing–remitting multiple sclerosis could soon be available.
Nature Reviews Drug Discovery News (November 2009)
| Full Text |
Trial watch: CGRP receptor antagonist meets Phase III migraine end points
Merck has announced that telcagepant, a small-molecule inhibitor of the calcitonin gene-related peptide (CGRP) receptor, has met the primary end points in two Phase III trials to treat migraine.
Nature Reviews Drug Discovery News (November 2009)
| Full Text |
News Features
The FDA: A tough tonic
Peggy Hamburg, the former health commissioner of New York City and current commissioner of the US Food and Drug Administration (FDA), hopes to apply some of the same approaches that improved public health in New York City to the FDA.
Nature News (26 November 2009)
| Full Text |
Computational Biology: Biological logic
An emerging field known as 'executable biology' could make computational models of cells and their signaling pathways easier for researchers to build, understand and verify experimentally.
Nature News (26 November 2009)
| Full Text |
Biodiversity: On the origin of bar codes
A 648-nucleotide stretch of mitochondrial DNA can be used as a 'barcode' to identify and distinguish between species.
Nature News (19 November 2009)
| Full Text |
The gold rush for induced pluripotent stem cells
As the first commercial ventures are formed around induced pluripotent stem (iPS) cell research, it is not yet clear which companies will have the technology and seed money necessary for success.
Nature Biotechnology News (November 2009)
| Full Text |
Straight talk with...Joan Scott
Nature Medicine talks to Joan Scott, the director of the US Genetics & Public Policy Center, about the implications of using gene-based technology.
Nature Medicine News (November 2009)
| Full Text |
|
